Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:2885-2890

This Article
Right arrow Full Text
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Khechai, F.
Right arrow Articles by de Prost, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Khechai, F.
Right arrow Articles by de Prost, D.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:2885-2890.)
© 1997 American Heart Association, Inc.


Articles

Effect of Advanced Glycation End Product–Modified Albumin on Tissue Factor Expression by Monocytes

Role of Oxidant Stress and Protein Tyrosine Kinase Activation

F. Khechai; V. Ollivier; F. Bridey; M. Amar; J. Hakim; ; D. de Prost

From INSERM U294 and Service d'Hématologie et d'Immunologie biologiques, CHU Xavier Bichat, Paris, France.

Correspondence to D. de Prost, Service d'Hématologie et d'Immunologie and INSERM (U294), CHU Bichat-Claude Bernard, 46 rue Henri Huchard, 75018, Paris, France.

Abstract Diabetes is associated with a hypercoagulable state that contributes to macrovascular complications, including cardiovascular events. The glycation reaction, a consequence of chronic hyperglycemia, has also been implicated in the pathogenesis of diabetic complications. Glycated proteins have receptors on monocytes and generate reactive oxygen species that can regulate the expression of a number of genes. As abnormal monocyte expression of tissue factor (TF), the main initiator of the coagulation cascade, is responsible for thrombosis in a number of clinical settings, we studied the effect of glycated albumin on monocyte TF expression. Mononuclear cells were incubated with glycated albumin for 24 hours, and monocyte TF activity was measured with a plasma recalcification time assay; TF antigen was measured by ELISA and TF mRNA by RT-PCR. Glycated albumin induced blood monocyte expression of the procoagulant protein TF at the mRNA level. Oxidative stress appeared to be involved in this effect, as the antioxidant N-acetylcysteine diminished TF mRNA accumulation in stimulated monocytes. Hydroxyl radicals, which may be generated inside cells from H2O2 via the Fenton reaction, also appeared to be involved in this effect, as hydroxyl radical scavengers downregulated TF activity and antigen levels (but not TF mRNA). Finally, the involvement of activated protein tyrosine kinase in the transmission of the signal from the membrane to the nucleus was suggested by the inhibitory effect of herbimycin A. These results point to a new mechanism for the hypercoagulability often described in diabetic patients and suggest that antioxidants or protein tyrosine kinase inhibitors might be of therapeutic value in this setting.


Key Words: glycation • oxidant stress • tissue factor • monocyte • thrombosis




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
Y. Wang, W. Beck, R. Deppisch, S. M. Marshall, N. A. Hoenich, and M. G. Thompson
Advanced glycation end products elicit externalization of phosphatidylserine in a subpopulation of platelets via 5-HT2A/2C receptors
Am J Physiol Cell Physiol, July 1, 2007; 293(1): C328 - C336.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Ding, A. Kantarci, J. A. Badwey, H. Hasturk, A. Malabanan, and T. E. Van Dyke
Phosphorylation of Pleckstrin Increases Proinflammatory Cytokine Secretion by Mononuclear Phagocytes in Diabetes Mellitus
J. Immunol., July 1, 2007; 179(1): 647 - 654.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
Y. Ding, A. Kantarci, H. Hasturk, P. C. Trackman, A. Malabanan, and T. E. Van Dyke
Activation of RAGE induces elevated O2- generation by mononuclear phagocytes in diabetes
J. Leukoc. Biol., February 1, 2007; 81(2): 520 - 527.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Cai, C. Song, I. Endoh, J. Goyette, W. Jessup, S. B. Freedman, H. P. McNeil, and C. L. Geczy
Serum Amyloid A Induces Monocyte Tissue Factor
J. Immunol., February 1, 2007; 178(3): 1852 - 1860.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. E. Stegenga, S. N. van der Crabben, M. Levi, A. F. de Vos, M. W. Tanck, H. P. Sauerwein, and T. van der Poll
Hyperglycemia Stimulates Coagulation, Whereas Hyperinsulinemia Impairs Fibrinolysis in Healthy Humans
Diabetes, June 1, 2006; 55(6): 1807 - 1812.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Niemetz, S. M. Day, N. Mackman, and W. P. Fay
Tissue-factor-endowed leukocytes do cause thrombosis
Blood, August 15, 2005; 106(4): 1506 - 1507.
[Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
D. W. Sommeijer, A. Beganovic, C. G. Schalkwijk, H. Ploegmakers, C. M. van der Loos, B. E. van Aken, H. ten Cate, and A. C. van der Wal
More Fibrosis and Thrombotic Complications but Similar Expression Patterns of Markers for Coagulation and Inflammation in Symptomatic Plaques from DM2 Patients
J. Histochem. Cytochem., September 1, 2004; 52(9): 1141 - 1149.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. M. Watson, A. K. C. Chan, L. R. Berry, J. Li, S. K. Sood, J. G. Dickhout, L. Xu, G. H. Werstuck, L. Bajzar, H. J. Klamut, et al.
Overexpression of the 78-kDa Glucose-regulated Protein/Immunoglobulin-binding Protein (GRP78/BiP) Inhibits Tissue Factor Procoagulant Activity
J. Biol. Chem., May 2, 2003; 278(19): 17438 - 17447.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Y. Yano, N. Kitagawa, E. C. Gabazza, K. Morioka, H. Urakawa, T. Tanaka, A. Katsuki, R. Araki-Sasaki, Y. Hori, K. Nakatani, et al.
Increased Plasma Thrombin-Activatable Fibrinolysis Inhibitor Levels in Normotensive Type 2 Diabetic Patients with Microalbuminuria
J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 736 - 741.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. I. Osende, J. J. Badimon, V. Fuster, P. Herson, P. Rabito, R. Vidhun, A. Zaman, O. J. Rodriguez, E. I. Lev, U. Rauch, et al.
Blood thrombogenicity in type 2 diabetes mellitus patients is associated with glycemic control
J. Am. Coll. Cardiol., November 1, 2001; 38(5): 1307 - 1312.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C.-H. Yeh, L. Sturgis, J. Haidacher, X.-N. Zhang, S. J. Sherwood, R. J. Bjercke, O. Juhasz, M. T. Crow, R. G. Tilton, and L. Denner
Requirement for p38 and p44/p42 Mitogen-Activated Protein Kinases in RAGE-Mediated Nuclear Factor-{kappa}B Transcriptional Activation and Cytokine Secretion
Diabetes, June 1, 2001; 50(6): 1495 - 1504.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
A. Mezzetti, F. Cipollone, and F. Cuccurullo
Oxidative stress and cardiovascular complications in diabetes: isoprostanes as new markers on an old paradigm
Cardiovasc Res, August 18, 2000; 47(3): 475 - 488.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. F. Keaney Jr and J. Loscalzo
Diabetes, Oxidative Stress, and Platelet Activation
Circulation, January 19, 1999; 99(2): 189 - 191.
[Full Text] [PDF]